PAULA NICHAELLE AQUINO: Open Payments
NPI 1831841006 · WAIPAHU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,745 in 56 payments from 15 companies in 2025. Trend: 2023 $799 · 2024 $1,766 · 2025 $1,745
Food & beverage: $1,745
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $279 |
| Dexcom, Inc. | 8 | $260 |
| Lilly USA, LLC | 9 | $230 |
| Novo Nordisk Inc | 8 | $194 |
| Boston Scientific Corporation | 3 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $150 |
| Corcept Therapeutics | 2 | $145 |
| ABBVIE INC. | 4 | $93 |
| Amgen Inc. | 4 | $87 |
| Esperion Therapeutics, Inc. | 2 | $36 |
Products named: FREESTYLE LIBRE 3, General - Pain Management, Kerendia, Korlym, DEXCOM G7 GSS (161), Dexcom G6 Transmitter, MOUNJARO, JARDIANCE.
Industry payments across HI — which companies pay providers there.
